Multiple Myeloma Clinical Trial

Clinical Trial Finder Multiple Myeloma Trials

Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma

See Locations Near You

Summary

The purpose of this study is to describe the real-world use of Belantamab Mafodotin - blmf (BLENREP) and associated patterns of care, including dosing and dose modification, eye care specialist visits, associated healthcare utilization, and clinical outcomes in patients with relapsed and/or refractory multiple myeloma (RRMM) seen in the Duke Cancer Institute (DCI) clinics.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age > 18 years of age as of start of treatment with BLENREP
Patients with a corresponding diagnosis code consistent with multiple myeloma seen at Duke.
Patients with a record of starting treatment with BLENREP for RRMM between August 5, 2020 and November 22, 2022.
Patients having healthcare encounters at Duke Cancer Institute (DCI) for at least 1-month after start of Blenrep treatment.

Exclusion Criteria:

Patients who were included in any clinical trial for BLENREP including expanded access clinical trials
Age > 89 years of age as of start of index therapy

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

30

Study ID:

NCT05986682

Recruitment Status:

Completed

Sponsor:

Duke University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Duke University Medical Center
Durham North Carolina, 27705, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

30

Study ID:

NCT05986682

Recruitment Status:

Completed

Sponsor:


Duke University

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider